Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo

Journal of Experimental Medicine

Volumn 184, Issue 4, 1996, Pages 1413-1424

  De Smedt, Thibaut ^a   Pajak, Bernard ^a   Muraille, Eric ^a   Lespagnard, Laurence ^a   Heinen, Ernst ^b   De Baetselier, Patrick ^c   Urbain, Jacques ^a   Leo, Oberdan ^a   Moser, Muriel ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL MATURATION; CELL MIGRATION; DENDRITIC CELL; FLOW CYTOMETRY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD80; ANTIGENS, DIFFERENTIATION; CELL DIFFERENTIATION; CELL MOVEMENT; CELL SEPARATION; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOHISTOCHEMISTRY; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; SPLEEN; UP-REGULATION;

EID: 0029905555     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.184.4.1413     Document Type: Article

References (66)

1. Thompson, C.B. 1995. Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation? Cell. 81:979-982.
2. Schwartz, R.H. 1990. A cell culture model for T lymphocyte clonal anergy. Science (Wash. DC). 248:1349-1356.
3. Linsley, P.S., P.M. Wallace, J. Johnson, M.G. Gibson, J.L. Greene, J.A. Ledbetter, C. Singh, and M.A. Tepper. 1992. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science (Wash. DC). 257:792-795.
4. Linsley, P.S., W. Brady, M. Urnes, L.S. Grosmaire, N.K. Damle, and J.A. Ledbetter. 1991. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174: 561-564.
5. Lenschow, D.J., G. Huei-Ting Su, L.A. Zuckerman, N. Nabavi, C.L. Jellis, G.S. Gray, J. Miller, and J.A. Bluestone. 1993. Expression and functional significance of an additional ligand for CTLA-4. Proc. Natl. Acad. Sci. USA. 90:11054-11058.
6. Lenschow, D.J., Y. Zeng, J.R. Thistlethwaite, A. Montag, W. Brady, M.G. Gibson, P.S. Linsley, and J.A. Bluestone. 1992. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science (Wash. DC). 257:789-792.
7. Turka, L.A., P.S. Linsley, H. Lin, W. Brady, J.M. Leiden, R. Wei, M.L. Gibson, X. Zhen, S. Myrdal, D. Gordon et al. 1992. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc. Natl. Acad. Sci. USA. 89:11102-11105.
8. Lin, H., S.F. Bolling, P.S. Linsley, R.-Q. Wei, D. Gordon, C.B. Thopmson, and L.A. Turka. 1993. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA-4-Ig plus donor-specific transfusion. J. Exp. Med. 178:1801-1806.
9. Steinman, R.M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271-296.
10. Inaba, K., M.D. Witmer, and R.M. Steinman. 1984. Clustering of dendritic cells, helper T lymphocytes, and histocompatible B cells, during primary antibody responses in vitro. J. Exp. Med. 160:858-876.
11. Kast, W.M., C.J.P. Boog, P.O. Roep, A.C. Voordouw, and C.J.M. Melief. 1988. Failure or success in the restoration of virus-specific cytotoxic T lymphocytes response defects of dendritic cells. J. Immunol. 14:3186-3193.
12. Macatonia, S.E., P.M. Taylor, S.D. Knight, and B.A. Askonas. 1989. Primary stimulation by dendritic cells induces anti-viral proliferative and cytotoxic T cell responses in vitro. J. Exp. Med. 169:1255-1264.
13. Steinman, R.M., B. Gutchinov, M.D. Witmer, and M.C. Nussenzweig. 1983. Dendritic cells are the principal stimulators of the primary mixed leukocyte reaction in mice. J. Exp. Med. 157:613-627.
14. + cytotoxic T lymphocytes by dendritic cells. J. Exp. Med. 166:182-194.
15. Britz, J.S., P.W. Askenase, W. Ptak, R.M. Steinman, and R.K. Gershon. 1982. Specialized antigen-presenting cells: splenic dendritic cells and peritoneal exudate cells induced by mycobacteria, activate effector T cells that are resistant to suppression. J. Exp. Med. 155:1344-1356.
16. Macatonia, S.E., S.C. Knight, A.J. Edwards, S. Griffiths, and P. Fryer. 1987. Localization of antigen on lymph nodes dendritic after exposure to the contact sensitizer fluorescein isothiocyanate. J. Exp. Med. 166:1654-1667.
17. Aiba, S., and S.I. Katz. 1990. Phenotypic and functional characteristics of in vivo-activated Langerhans cells. J. Immunol. 145:2791-2796.
18. Lechler, R.I., and J.R. Batchelor. 1982. Restauration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J. Exp. Med. 155: 31-41.
19. Faustman, D., R.M. Steinman, H. Geble, V. Hauptfeld, J. Davie, and P. Lacy. 1984. Prevention of rejection of murine islets allograft by pretreatment with anti-dendritic cell antibody. Proc. Natl. Acad. Sci. USA. 81:3864-3868.
20. Larsen, C.P., P.J. Morris, and J.M. Austyn. 1990. Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection. J. Exp. Med. 171:307-314.
21. Boog, C.J.P., W.M. Kast, H. Thy, M. Timmers, J. Boes, L.P. de Waal, and C.J.M. Melief. 1985. Abolition of specific immune response defect by immunization with dendritic cells. Nature (Lond.). 318:59-62.
22. Inaba, K., M.T. Metlay, M.T. Crowley, and R.M. Steinman. 1990. Dendritic cells pulsed with antigens in vitro can prime antigen-specific, major histocompatibility complex-restricted T cells in situ. J. Exp. Med. 172:631-640.
23. Sornasse, T., V. Flamand, G. De Becker, H. Bazin, F. Tielemans, K. Thielemans, J. Urbain, O. Leo, and M. Moser. 1992. Antigen-pulsed dendritic cells can efficiently induce an antibody response in vivo. J. Exp. Med. 175:15-21.
24. Flamand, V., T. Sornasse, K. Thielemans, C. Demanet, M. Bakkus, H. Bazin, F. Tielemans, O. Leo, J. Urbain, and M. Moser. 1994. Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur. J. Immunol. 24:605-610.
25. Larsen, C.P., S.C. Ritchie, T.C. Pearson, P.S. Linsley, and R.P. Lowry. 1992. Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations. J. Exp. Med. 176:1215-1220.
26. Inaba, K., M. Witmer-Pack, M. Inaba, K.S. Hathcock, H. Sakuta, M. Azuma, H. Yagita, K. Okumura, P.S. Linsley, S. Ikehara et al. 1994. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J. Exp. Med. 180:1849-1860.
27. Moser, M., T. De Smedt, T. Sornasse, F. Tielemans, A.A. Chentoufi, E. Muraille, M. Van Mechelen, J. Urbain, and O. Leo. 1995. Glucocorticoids down-regulate dendritic cell function in vitro and in vivo. Eur. J. Immunol. 25:2818-2824.
28. Romani, N., S. Koide, M. Crowley, M. Witmer-Pack, A.M. Livingstone, C.G. Fathman, K. Inaba, and R.M. Steinman. 1989. Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells. J. Exp. Med. 169: 1169-1178.
29. Crowley, M.T., K. Inaba, M.D. Witmer-Pack, S. Gezelter, and R.M. Steinman. 1990. Use of the fluorescence activated cell sorter to enrich dendritic cells from mouse spleen. J. Immunol. Methods. 133:55-66.
30. Koch, F., B. Trockenbacher, E. Kämpgen, O. Grauer, H. Stössel, A.M. Livingstone, G. Schuler, and N. Romani. 1995. Antigen processing in populations of mature murine dendritic cells is caused by subsets of incompletely matured cells. J. Immunol. 155:93-100.
31. Harding, F.A., J.G. McArthur, J.A. Gross, D.H. Raulet, and J.P. Allison. 1992. CD28 mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature (Lond.). 356:607-609.
32. Leo, O., M. Foo, D. Sachs, L.E. Samelson, and J. Bluestone. 1987. Identification of a monoclonal antibody specific from a murine T3 peptide. Proc. Natl. Acad. Sci. USA. 84:1374-1378.
33. d mice. J. Exp. Med. 175:157-162.
34. Naquet, P., J. Ellis, B. Singh, R.S. Hodges, and T.L. Delovitch. 1987. Processing of insulin. I. Analysis of immunogenic peptides and processing requirements for insulin A loop-specific T cells. J. Immunol. 139:3955-3963.
35. Metlay, J.P., M.D. Witmer-Pack, R. Agger, M.T. Crowley, D. Lawless, and R.M. Steinman. 1990. The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies. J. Exp. Med. 171: 1753-1771.
36. Razi-Wolf, Z., F. Galvin, G. Gray, and H. Reiser. 1993. Evidence for an additional ligand, distinct from B7, for CTLA-4 receptor. Proc. Natl. Acad. Sci. USA. 90:11182-11186.
37. Hathcock, K.S., G. Lazlo, H.B. Dickler, J. Bradshaw, P. Linsley, and R.J. Hodes. 1993. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science (Wash. DC). 262:905-907.
38. Crowley, M., K. Inaba, M. Witmer-Pack, and R.M. Steinman. 1989. The cell surface of mouse DC: FACS analyses of DC from different tissues including thymus. Cell. Immunol. 118:108-125.
39. Kraal, G., M. Breel, M. Jnase, and G. Bruin. 1986. Langerhans cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal antibody. J. Exp. Med. 163: 981-997.
40. Agger, R., M. Witmer-Pack, N. Romani, H. Stossel, W.J. Swiggard, J.P. Metlay, E. Storozynsky, P. Freimuth, and R.M. Steinman. 1992. Two populations of splenic dendritic cells detected with M342, a new monoclonal to an intracellular antigen of interdigitating dendritic cells and some B lymphocytes. J. Leukoc. Biol. 52:34-42.
41. Inaba, K., W.J. Swiggard, M. Inaba, J. Meltzer, A. Mirza, T. Sasagawa, M.C. Nussenzweig, and R.M. Steinman. 1995. Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145. I. Expression on dendritic cells and other subsets of mouse leukocytes. Cell. Immunol. 163:148-156.
42. Bhardwaj, N., J.W. Young, A.J. Nisanian, J. Baggers, and R.M. Steinman. 1993. Small amounts of superantigens, when presented on dendritic cells, are sufficient to initiate T cell responses. J. Exp. Med. 178:633-642.
43. Muraille, E., G. De Becker, M. Bakkus, K. Thielemans, J. Urbain, M. Moser, and O. Leo. 1995. Co-stimulation lowers the threshold for activation of naive T cells by bacterial superantigens. Int. Immunol. 152:5208-5219.
44. Leo, O., D.H. Sachs, L.E. Samelson, M. Foo, R. Quinones, R. Gress, and J.A. Bluestone. 1986. Identification of monoclonal antibodies specific for the T cell receptor complex by Fc receptor-mediated CTL lysis. J. Immunol. 137:3874-3880.
45. Jiang, W., W.J. Swiggard, C. Heufler, M. Peng, A. Mirza, R.M. Steinman, and M.C. Nussenzweig. 1995. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature (Lond.). 375: 151-155.
46. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science (Wash. DC). 267:1449-1456.
47. Vandenabeele, P., W. Declercq, R. Beyaert, and W. Fiers. 1995. Two tumor necrosis factor receptors: structure and function. Trends Cell Biol. 5:392-399.
48. Kupiec-Weglinski, J.W., J.M. Austyn, and P.J. Morris. 1988. Migration patterns of dendritic cells in the mouse. Traffic from the blood, and T cell-dependent and -independent entry to lymphoid tissues. J. Exp. Med. 167:632-645.
49. Abraham, E., and R.F. Regan. 1985. The effects of hemorrhage and trauma on interleukin 2 production. Arch. Surg. 120:1341-1344.
50. Grbic, J.T., J.A. Mannick, D.B. Gough, and M.L. Rodrick. 1991. The role of prostaglandin E2 in immune suppression following injury. Ann. Surg. 214:253-263.
51. Ayala, A., Z.K. Deol, D.L. Lehman, C.D. Herdon, and I.H. Chaudry. 1994. Polymicrobial but not low-dose endotoxin infusion causes decreased splenocyte IL-2/IFN-γ release while increasing IL-4/IL-10 production. J. Surg. Res. 56: 579-585.
52. Groeneveld, P.H.P., T. Erich, and G. Kraal. 1986. The differential effects of bacterial lipopolysaccharide (LPS) on splenic non-lymphoid cells demonstrated by monoclonal antibodies. Immunology. 58:285-290.
53. MacPherson, G.G., C.D. Jenkins, M.J. Stein, and C. Edwards. 1995. Endotoxin-mediated dendritic cell release from the intestine. Characterization of released dendritic cells and TNF dependence. J. Immunol. 154:1317-1322.
54. Roake, J.A., A.S. Rao, P.J. Morris, C.P. Larsen, D.F. Hankins, and J.M. Austyn. 1995. Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J. Exp. Med. 181:2237-2247.
55. Schon-Hegrad, M.A., J. Oliver, P.G. McMenamin, and P.G. Holt. 1991. Studies on the density, distribution, and surface phenotype of intraepithelial class II major histocompatibility complex antigen (Ia)-bearing dendritic cells in the conducting airways. J. Exp. Med. 173:1345-1356.
56. Sallusto, F., M. Cella, C. Danieli, and A. Lanzavecchia. 1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182:389-400.
57. Knight, S.C., P. Bedford, and R. Hunt. 1985. The role of dendritic cells in the initiation of immune responses to contact sensitizers. II. Studies in nude mice. Cell. Immunol. 94:435-139.
58. Austyn, J.M., J.W. Kupiec-Weglinski, D.F. Hankins, and P.J. Morris. 1988. Migration patterns of dendritic cells in the mouse. Homing to T cell-dependent areas of spleen, and binding within marginal zone. J. Exp. Med. 167:646-651.
59. Heufler, C., F. Koch, and G. Schuler. 1988. Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of epidermal Langerhans cells into potent immunostimulatory dendritic cells. J. Exp. Med. 167: 700-705.
60. Cumberbatch, M., and I. Kimber. 1992. Dermal tumor necrosis factor-α induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans cell migration. Immunology. 75:257-263.
61. Cumberbatch, M., and I. Kimber. 1995. Tumor necrosis factor-α is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization. Immunology. 84:31-35.
62. Koide, S.L., K. Inaba, and R.M. Steinman. 1987. Interleukin 1 enhances T cell-dependent immune responses by amplifying the function of dendritic cells. J. Exp. Med. 165:515-530.
63. Kanangat, S., S. Nair, J.S. Babu, and B.T. Rouse. 1995. Expression of cytokine mRNA in murine splenic dendritic cells and better induction of T cell-derived cytokines by dendritic cells than by macrophages during in vitro costimulation assay using specific antigens. J. Leukoc. Biol. 57:310-316.
64. Granucci, F., G. Girolomoni, M.B. Lutz, M. Foti, G. Marconi, P. Gnocchi, L. Nolli, and P. Ricciardi-Castagnoli. 1994. Modulation of cytokine expression in mouse dendritic cell clones. Eur. J. Immunol. 24:2522-2526.
65. Janeway, C. 1989. Immunogenicity signals 1, 2, 3 . . . and 0. Immunol. Today. 10:286-289.
66. Liu, Y., and C.A. Janeway. 1991. Microbial induction of costimulatory activity for CD4 T-cell growth. Int. Immunol. 3: 323-332.